Trials / NCT06242379
Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa
Recruiting now Phase 1 / Phase 2 Cell therapy
- Sponsor
- Mahidol University
- Treatment
- GMP compliant-BM-MSC derived sEVs
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- 18 Years to no upper limit
- Enrollment
- 15 participants
- Started
- 2024-05-23
- Main results expected
- 2026-12-31
- Results posted
- Not yet
- Record last updated
- 2025-05-15
What the study is testing
The aim of this clinical trials is to evaluate the safety and efficacy of intravitreal injection of GMP-compliant BM-MSC-derived sEVs in patients with retinitis pigmentosa.
Where it runs
Thailand (1)
- Siriraj Hospital, Bangkok Noi, Bangkok (recruiting now)